If you liked this article you might like

Can Abbott Outperform Despite Alere?
Consumers Are Spending in Plain Sight: Cramer's 'Mad Money' Recap (Thursday 3/16/17)
After Soaring to $150, Can Incyte Stir Up More Upside?
Chaos Is Biggest Threat to Wednesday's Vote on Repealing Obamacare